Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Chloramphenicol sodium succinate 1.4 g equivalent to 1 g chloramphenicol
Link Pharmaceuticals Ltd
Chloramphenicol sodium succinate 1.4 g (equivalent to 1 g chloramphenicol)
1 g
Powder for injection
Active: Chloramphenicol sodium succinate 1.4 g equivalent to 1 g chloramphenicol
Vial, glass, single dose, 10 x 1g, 10 g
Prescription
Prescription
Quimica Sintetica SA
Package - Contents - Shelf Life: Vial, glass, single dose, 10 x 1g - 10 g - 36 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
1969-12-31
Medsafe Logo INFORMATION FOR HEALTH PROFESSIONALS Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search Data Sheet CHLOROMYCETIN ® SUCCINATE Chloromycetin sodium succinate powder for injection. Chloromycetin Succinate contains the active component chloramphenicol sodium succinate. Chemical Name: Chloramphenicol sodium succinate is a mixture of variable proportions of sodium (2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)-propyl succinate ('3-isomer') and sodium (1R,2R)-2-(2,2-dichloroacetamido)-3-hydroxy-1-(4-nitrophenyl) propyl succinate ('1-isomer'). Description Chloramphenicol sodium succinate is a white or yellowish-white hygroscopic powder. It is soluble 1 in less than 1 part of water, 1 in 1 part of alcohol; practically insoluble in chloroform and ether. A 25% solution in water has a pH of 6.4 to 7.0. Each vial of Chloromycetin Succinate contains chloramphenicol sodium succinate equivalent to 1 g of chloramphenicol. Empirical Formula: C 15 H 15 Cl 2 N 2 NaO 8 MW: 445.2 Pharmacology Chloramphenicol sodium succinate is a prodrug. After parenteral administration it is hydrolysed in the liver to produce free active chloramphenicol. The rate of hydrolysis is variable in different individuals. Chloramphenicol is effective in a wide variety of bacterial and rickettsial infections. It possesses high antimicrobial activity, crosses tissue barriers readily, and diffuses widely and rapidly through nearly all body tissues and fluids. Pharmacokinetics Inter-individual variation exists in determining the pharmacokinetics for a given patient with impaired and/or immature hepatic or renal function (see DOSAGE AND ADMINISTRATION). Intramuscular chloramphenicol sodium succinate may produce lower blood concentrations than identical intravenous doses. Intramuscul Read the complete document